Astrazeneca plc, Pharmaceutical company

London, July 30 AstraZeneca's intranasal Covid vaccination reduced virus concentrations and curbed transmission in two different SARS-CoV-2 animal models, demonstrating the need for further investigation as a potential method of inoculating Covid-19 shots.The trial, led by researchers including from the US National Institutes of Health (NIH) and the University of Oxford, UK, was published in the journal Science Translational Medicine.While previous studies in rhesus macaques revealed that intramuscular vaccination with AstraZeneca Covid shot provided protection against pneumonia, it did not reduce shedding of SARS-CoV-2 from the upper respiratory tract.In the new study, intranasal vaccination of rhesus macaques and hamsters resulted in reduced virus concentrations in nasal swabs and a reduction in viral loads in bronchoalveolar lavage and lower respiratory tract tissue."The data presented supports the investigation of intranasal delivery of Covid-19 vaccines. With the roll-out of Covid-19 vaccines worldwide, it will be crucial to investigate whether the vaccines provide sterilising immunity, or whether vaccinated people are still susceptible to infection of the upper respiratory tract and onward transmission of the virus," Vincent J Munster, from the Laboratory of Virology at the NIH's National Institute of Allergy and Infectious Diseases.The data presented here demonstrates SARS-CoV-2-specific mucosal immunity is possible after intranasal vaccination, and results in a reduction in virus detection in nasal swabs in hamsters and macaques, he added.The team investigated whether intranasally administered ChAdOx1 nCoV-19 (AstraZeneca's intranasal Covid vaccine) reduces detection of virus in nasal swabs after challenging vaccinated macaques and hamsters with SARS-CoV-2 carrying a D614G mutation (the original Covid variant) in the spike protein."Viral loads in swabs obtained from intranasally vaccinated hamsters were decreased compared to control hamsters, and no viral RNA or infectious virus was found in lung tissue after a direct challenge or after direct contact with infected hamsters," Munster said.The macaques "exhibited low titers of IgG and IgA antibodies in nasosorption samples coupled with low virus neutralising (VN) and sera IgG titers, suggesting that a robust humoral response in the nasal mucosa and in circulation is necessary to efficiently control nasal shedding," he added.Although protection of the lower respiratory tract was complete in intranasal-vaccinated animals, only partial control was seen in intramuscular-vaccinated animals, in contrast to the direct challenge experiment, the researchers said.The team also mentioned that the animal numbers were limited and although differences were observed and were very encouraging between intranasally vaccinated and control animals, these were not significant.The University of Oxford has started a phase 1 clinical trial including 54 healthy adults to investigate intranasal vaccination of human volunteers.Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Astrazeneca PlcFOLLOW

Astrazeneca plc, Latest News

Kathmandu, Aug 6 Nepal on Friday received 300,000 doses of the AstraZeneca Covid-19 vaccines supplied by Bhutan, which ... ...

The Russian Direct Investment Fund on Wednesday announced that combination of the first component of Sputnik V vaccine with vaccines by AstraZeneca, Sinopharm, and Moderna demonstrated favorable results. ...

The German government has announced that it will donate all future orders for the AstraZeneca vaccine to the COVAX initiative with the support of the United Nations. ...

Mixing of COVID-19 vaccines should be done with the ones available in India, Dr Gagandeep Kang, Christian Medical College, Vellore's professor, and top microbiologist and virologist said on Thursday adding that it will help to overcome the vaccine sh ...

The Russian Direct Investment Fund on Wednesday announced that combination of the first component of Sputnik V vaccine with vaccines by AstraZeneca, Sinopharm, and Moderna demonstrated favorable results. ...

The German government has announced that it will donate all future orders for the AstraZeneca vaccine to the COVAX initiative with the support of the United Nations. ...

Sydney, Aug 1 Covid-19 cannot enter a person's DNA, say Australian researchers refuting claims of SARS-CoV-2, the virus ... ...

London, July 30 AstraZeneca's intranasal Covid vaccination reduced virus concentrations and curbed transmission in two different SARS-CoV-2 animal ... ...